Deep Brain Stimulation (DBS) is a neurosurgical intervention that delivers electrical stimulation to specific deep brain nuclei via implanted electrodes, modulating pathological neural circuit activity to alleviate neurological symptoms. DBS is the most widely deployed implanted neural interface, with over 200,000 patients treated worldwide and FDA approval for Parkinson's disease, essential tremor, dystonia, OCD, and epilepsy.

How DBS Works

DBS does not lesion brain tissue (unlike earlier ablative approaches such as pallidotomy). Instead, it delivers continuous high-frequency (typically 130–185 Hz) electrical pulses through electrode contacts placed in the target nucleus. The precise mechanism is debated — high-frequency stimulation may:

  • Suppress pathological oscillatory activity (e.g., beta oscillations in Parkinson's)
  • Activate axons projecting out of the stimulation site
  • Block information transmission through the target nucleus
  • Modulate activity throughout the broader circuit

DBS Targets by Indication

| Indication | Primary Target | Alternative Target | |---|---|---| | Parkinson's disease (motor) | Subthalamic nucleus (STN) | Globus pallidus interna (GPi) | | Essential tremor | Ventral intermediate nucleus of thalamus (Vim) | STN, caudal zona incerta | | Dystonia | Globus pallidus interna (GPi) | STN | | OCD | Anterior limb of internal capsule (ALIC) | Nucleus accumbens | | Epilepsy | Anterior thalamus (ANT) | Centromedian nucleus (CM) | | Depression (investigational) | Subgenual cingulate (Area 25) | Ventral striatum |

Closed-Loop and Adaptive DBS

Standard ("open-loop") DBS delivers constant stimulation regardless of the patient's brain state — like a pacemaker set to a fixed rate. The next generation of DBS is adaptive or closed-loop:

  • Medtronic Percept PC (BrainSense): Records subthalamic LFP in real time; adaptive DBS algorithms under development detect elevated beta power (a Parkinson's symptom biomarker) and increase stimulation intensity in response
  • Abbott Infinity / Boston Scientific Vercise: Directional leads with multiple independent current sources enable steering of the stimulation field to maximize therapeutic effect while minimizing side effects

DBS vs. BCI

While DBS devices like the Percept PC include bidirectional sensing that technically qualifies them as BCIs, they are conventionally distinguished:

  • DBS: Primarily a stimulation therapy; sensing is used for optimization, not direct user control
  • Communication/motor BCI: Primarily decoding neural signals for user control of external devices

The distinction is blurring as closed-loop DBS systems evolve toward reading more nuanced neural states to adapt therapy in real time.